Below you will find ASCO positions as expressed in policy statements, issue statements, and letters. Information on current ASCO actions is available in the categories listed on the right.

Access & Quality Issues:

• Issue Statement: Drug Shortages (August 2011)
  
  
• ASCO Policy Statement: Opportunities in the Patient Protection and Affordable Care Act to Reduce Cancer Care Disparities (August 2011)
  
  
• ASCO Policy Statement: Toward Individualized Care for Patients With Advanced Cancer (January 2011)
  
  
• ASCO Guidance Statement: The Cost of Cancer Care (August 2009)
  
  
• ASCO Policy Statement: Disparities in Cancer Care (June 2009)


• ASCO Policy Statement: Palliative Cancer Care a Decade Later: Accomplishments, the Need, Next Steps (May 2009)
  
  

Cancer Prevention Issues:

• ASCO Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility (January 2010)
  
  
• ASCO Policy Statement: The Role of the Oncologist in Cancer Prevention and Risk Assessment (February 2009, current as of August 2011)
  
  
• ASCO Policy Statement Update: Tobacco Control: Reducing Cancer Incidence and Saving Lives (May 2003)
  
  

Cancer Research Issues:

• ASCO Statement on Minimum Standards and Exemplary Attributes of Clinical Trials Sites (April 2008)


• ASCO Position Statement: Ethical, Scientific, and Regulatory Perspectives Regarding the Use of Placebos in Cancer Clinical Trials (January 2008)


• ASCO Position Statement on Coverage of Routine Patient Care Costs in Clinical Trials (March 2005)


• ASCO Position Statement on the Definition of a Quality Clinical Trial (March 2005)
  
  
• ASCO Policy Statement: Oversight of Clinical Research (November 2002)
  
  

Medicare Issues:

• Issue Statement: Comprehensive Cancer Care Improvement Act (February 2012)


• Issue Statement: Sustainable Growth Rate Formula (August 2011)
  
  
• Issue Statement: Average Sales Price Methodology (April 2011)


• Special Commentary: The Sustainable Growth Rate by Allen S. Lichter, MD, CEO of ASCO (June 2010)


• ASCO Policy Statement: Reimbursement for Cancer Treatment: Coverage of Off-Label Drug Indications (February 2006)
  
  

Practice Management Issues:

• ASCO-ONS Standards for Safe Chemotherapy Administration (November 2011)